top of page

General Critical Care

Public·1274 members

PEERLESS Trial


Thank you for posting this summary. it is probably sealing options to conisder any kind of thrombolytics in catheter directed approach of therapies for submassive PE. An interesting question would be which catheter directed thrombectomy is preferred.

70-year-old male presents with one month of hemoptysis and shortness of breath. Acute renal failure, anemia, bilateral infiltrates on chest X-ray.

CT scan of the chest:



Kidney profile:

Bronchoscopy


@Everyone

Edited

Analgesia and Sedation Use During Noninvasive Ventilation for Acute Respiratory Failure

Critical Care Medicine (lww.com)


This study examines the use of analgesia and sedation during noninvasive ventilation (NIV) for acute respiratory failure (ARF) across 1,017 U.S. hospitals. Among 433,357 patients, 26.7% received analgesia or sedation, with opioids (11.7%) and benzodiazepines (9.4%) being most common. Medication use was linked to higher odds of intubation (7.4%) or death (5.6%). Patients receiving any study medication had a 38% increased odds of intubation or mortality (aOR 1.38, 95% CI 1.35–1.40). The study highlights potential risks, especially with combinations like opioids and benzodiazepines, and calls for further research.

We use dexmedetomidine frequently in pts on NIV and does not cause respiratory depression

The liver and kidney in pulmonary hypertension and right heart failure. A, Acute ischemic hepatitis and congestive hepatopathy. Right inset, Centrilobular necrosis in ischemic hepatitis. Left inset, Chronic hepatic congestion with sinusoidal dilatation and portal fibrosis. B, Congestive nephropathy. Right inset, Low perfusion kidney injury caused by hypoperfusion and ischemia, demonstrating fibrosis (*), necrotic cells (arrowhead), and intraluminal debris. Left inset, Congestive nephropathy, characterized by interstitial edema, swollen tubule cells, and tubular compression. ALAT indicates alanine transaminase; AP, arterial pressure; ASAT, aspartate aminotransferase; CVP, central venous pressure; LDH, lactic acid dehydrogenase; and yGT, gamma-glutamyl transpeptidase.

Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure | Circulation (ahajournals.org)

RV dilation and TR associated with PE

LOOKS LIKE AIR BUBBLES MORE THAN SMOOKY FLOW?

IF YOU SCAN THE IVC TO SEE WHER THEY COM FROM




Paraplegic patient secondary to traumatic spinal injury with large amount of right main bronchial secretions causing right lung volume loss. Opened up after clearing all secretions. Required multiple bronchoscopies.

Chest X-ray with right lower/middle lobe infiltrate

Turned out to be effusion in the minor fissure on the CT scan.


Noor Ali Shah
Noor Ali Shah
Oct 18, 2023

Parapneumic effusion?

Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC)

In this study, the effectiveness of different oxygenation strategies in intensive care unit (ICU) patients was investigated. The aim was to determine if a low-oxygenation strategy, targeting lower levels of oxygen in the blood, would lead to lower 28-day mortality compared to a high-oxygenation strategy, where higher oxygen levels were maintained.


The study involved a randomized multicenter trial with mechanically ventilated ICU patients who were expected to require ventilation for at least 24 hours. Patients were divided into two groups: the low-oxygenation group (targeting a PaO2 of 55-80 mmHg or SpO2 of 91-94%) and the high-oxygenation group (targeting a PaO2 of 110-150 mmHg or SpO2 of 96-100%). The primary outcome assessed was 28-day mortality.


Between November 2018 and November 2021, a total of 664 patients were included in the trial. The achieved PaO2 levels were 75 mmHg in the…


Extracorporeal Membrane Oxygenation for Refractory Asthma Exacerbations With Respiratory Failure

The research paper examined the use of ECMO as a salvage therapy for refractory AERF and its impact on mortality. The study analyzed 13,714 AERF patients, with 127 receiving ECMO and 13,587 without it. ECMO was associated with reduced mortality in different models (OR ranging from 0.33 to 0.61) compared to standard care. However, ECMO was linked to higher hospital costs without significant effects on ICU or hospital length of stay or time on invasive ventilation. Confirmatory clinical trials are needed to validate ECMO's role as an important salvage therapy for refractory AERF.


Perspective:

ECMO shows promise in reducing mortality for refractory AERF, but further research and clinical trials are crucial to confirm its benefits and assess cost-effectiveness. As physicians, we should consider these findings when managing critically ill AERF patients, weighing the potential mortality benefits against the associated hospital…


Dr-Yasser Alwali
Jul 29, 2023

insha'Allah, ECMO will be available in the future in our country

Should Patients with COPD Exacerbation Undergo Imaging for VTE?

A prospective study conducted in 11 hospitals in China aimed to investigate the prevalence and risk factors for venous thromboembolism (VTE) in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD). The study included nearly 1600 patients who underwent laboratory and imaging screening for VTE, including bilateral lower-extremity ultrasound, computed tomography pulmonary angiography (CTPA), and echocardiogram, and were followed for 1 year. The results showed a VTE prevalence of 25%, with two-thirds of identified VTEs being pulmonary embolisms (PEs), mostly in large vessels. Patients with VTE had significantly higher 1-year mortality compared to those without VTE. The study also identified risk factors associated with VTE, such as cor pulmonale, elevated B-type natriuretic peptide level, or history of VTE, while purulent sputum was associated with a lower risk. Notably, D-dimer elevation was not strongly predictive of VTE. These findings prompt…


Dr-Yasser Alwali
Jul 29, 2023

Is it reasonable to undergo all chronic obstructive pulmonary disease patients during exacerbation to routine CTPA Because it is expensive and the contrast causes problems



ghazwanacash2
Apr 08, 2023

Thank you!

Using inhaled TXA 500 mg Q8h x3 days has good effects in submassive hemoptysis and may prevent progression.


For more Best Practices Infographics, please visit https://www.icureach.com/best-practices

A systematic review and meta-analysis of prone positioning (PP) for non-intubated COVID-19 patients was published in critical care medicine. The study aimed to systematically synthesize the outcomes associated with PP for non-intubated COVID-19 patients. The primary outcome was the reported cumulative intubation risk, while secondary outcomes included mortality, need for escalating respiratory support, hospital length of stay, ICU admission, and adverse events.

The study found that PP significantly reduced the intubation risk compared to supine position. Subgroup analysis showed a significant reduction in intubation risk among patients supported by high-flow nasal cannula (HFNC) or noninvasive ventilation (NIV) but not in patients with conventional oxygen therapy. No significant reduction was seen in mortality, need for escalating respiratory support, hospital length of stay, ICU admission and adverse events.